questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Pyridines
Composés de pyridinium
Composés de pyridinium : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Tests sanguins
Analyse chromatographique
Spectrométrie
Nausées
Troubles neurologiques
Tests urinaires
Métabolites
Historique médical
Symptômes
Symptômes
5
Douleurs abdominales
Troubles respiratoires
Éruptions cutanées
Irritations
Évolution des symptômes
Intervention rapide
Prévention
5
Équipements de protection
Exposition
Formations
Sécurité chimique
Fuites
Protocoles de sécurité
Traitements
5
Décontamination
Antidotes
Soins de soutien
Hydratation
Surveillance
Complications
Complications
5
Lésions organiques
Troubles respiratoires
Effets à long terme
Troubles cognitifs
Prise en charge médicale
Suivi régulier
Intervention rapide
Traitement approprié
Difficultés respiratoires
Confusion mentale
Facteurs de risque
5
Travailleurs en chimie
Industrie
Jeunes enfants
Personnes âgées
Antécédents médicaux
Maladies respiratoires
Conditions environnementales
Chaleur
Interactions médicamenteuses
Toxicité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés de pyridinium : Questions médicales les plus fréquentes",
"headline": "Composés de pyridinium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés de pyridinium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-05",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés de pyridinium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyridines",
"url": "https://questionsmedicales.fr/mesh/D011725",
"about": {
"@type": "MedicalCondition",
"name": "Pyridines",
"code": {
"@type": "MedicalCode",
"code": "D011725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cétylpyridinium",
"alternateName": "Cetylpyridinium",
"url": "https://questionsmedicales.fr/mesh/D002594",
"about": {
"@type": "MedicalCondition",
"name": "Cétylpyridinium",
"code": {
"@type": "MedicalCode",
"code": "D002594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.232"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diquat",
"alternateName": "Diquat",
"url": "https://questionsmedicales.fr/mesh/D004178",
"about": {
"@type": "MedicalCondition",
"name": "Diquat",
"code": {
"@type": "MedicalCode",
"code": "D004178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.352"
}
}
},
{
"@type": "MedicalWebPage",
"name": "1-Méthyl-4-phényl-pyridinium",
"alternateName": "1-Methyl-4-phenylpyridinium",
"url": "https://questionsmedicales.fr/mesh/D015655",
"about": {
"@type": "MedicalCondition",
"name": "1-Méthyl-4-phényl-pyridinium",
"code": {
"@type": "MedicalCode",
"code": "D015655",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorure d'obidoxime",
"alternateName": "Obidoxime Chloride",
"url": "https://questionsmedicales.fr/mesh/D009768",
"about": {
"@type": "MedicalCondition",
"name": "Chlorure d'obidoxime",
"code": {
"@type": "MedicalCode",
"code": "D009768",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Paraquat",
"alternateName": "Paraquat",
"url": "https://questionsmedicales.fr/mesh/D010269",
"about": {
"@type": "MedicalCondition",
"name": "Paraquat",
"code": {
"@type": "MedicalCode",
"code": "D010269",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.621"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bromure de pyridostigmine",
"alternateName": "Pyridostigmine Bromide",
"url": "https://questionsmedicales.fr/mesh/D011729",
"about": {
"@type": "MedicalCondition",
"name": "Bromure de pyridostigmine",
"code": {
"@type": "MedicalCode",
"code": "D011729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.740"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trimédoxime",
"alternateName": "Trimedoxime",
"url": "https://questionsmedicales.fr/mesh/D014289",
"about": {
"@type": "MedicalCondition",
"name": "Trimédoxime",
"code": {
"@type": "MedicalCode",
"code": "D014289",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Viologènes",
"alternateName": "Viologens",
"url": "https://questionsmedicales.fr/mesh/D014755",
"about": {
"@type": "MedicalCondition",
"name": "Viologènes",
"code": {
"@type": "MedicalCode",
"code": "D014755",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.925"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzyl viologène",
"alternateName": "Benzyl Viologen",
"url": "https://questionsmedicales.fr/mesh/D001594",
"about": {
"@type": "MedicalCondition",
"name": "Benzyl viologène",
"code": {
"@type": "MedicalCode",
"code": "D001594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.925.100"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés de pyridinium",
"alternateName": "Pyridinium Compounds",
"code": {
"@type": "MedicalCode",
"code": "D011726",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sungwoo Hong",
"url": "https://questionsmedicales.fr/author/Sungwoo%20Hong",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr."
}
},
{
"@type": "Person",
"name": "Werner Fudickar",
"url": "https://questionsmedicales.fr/author/Werner%20Fudickar",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Potsdam, Potsdam, Germany."
}
},
{
"@type": "Person",
"name": "Torsten Linker",
"url": "https://questionsmedicales.fr/author/Torsten%20Linker",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Potsdam, Potsdam, Germany."
}
},
{
"@type": "Person",
"name": "Lihua Luo",
"url": "https://questionsmedicales.fr/author/Lihua%20Luo",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China."
}
},
{
"@type": "Person",
"name": "Rui Sun",
"url": "https://questionsmedicales.fr/author/Rui%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Communication Overload in Hospitals: Exploring Organizational Safety Communication, Worker Job Attitudes, and Communication Efficacy.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36172847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10410236.2022.2129313"
}
},
{
"@type": "ScholarlyArticle",
"name": "Strategic communication as planned behavior for science and risk communication: A theory-based approach to studying communicator choice.",
"datePublished": "2022-09-18",
"url": "https://questionsmedicales.fr/article/36116781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/risa.14029"
}
},
{
"@type": "ScholarlyArticle",
"name": "Communication Openings: A Novel Approach for Serious Illness Communication in Homecare.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37906048",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/00989134-20231011-02"
}
},
{
"@type": "ScholarlyArticle",
"name": "Everyday Barriers in Communicative Participation According to People With Communication Problems.",
"datePublished": "2023-02-14",
"url": "https://questionsmedicales.fr/article/36787154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00405"
}
},
{
"@type": "ScholarlyArticle",
"name": "Beyond dyadic communication: Network of communication in inflammatory arthritis teams.",
"datePublished": "2022-05-29",
"url": "https://questionsmedicales.fr/article/35635126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/17423953221102629"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pyridines",
"item": "https://questionsmedicales.fr/mesh/D011725"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composés de pyridinium",
"item": "https://questionsmedicales.fr/mesh/D011726"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés de pyridinium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés de pyridinium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés de pyridinium",
"description": "Comment diagnostiquer une intoxication aux composés de pyridinium ?\nQuels tests sont utilisés pour détecter les composés de pyridinium ?\nQuels symptômes indiquent une exposition aux pyridiniums ?\nLes tests urinaires peuvent-ils détecter les pyridiniums ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Communication#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés de pyridinium",
"description": "Quels sont les symptômes courants d'une exposition aux pyridiniums ?\nLes composés de pyridinium provoquent-ils des effets neurologiques ?\nY a-t-il des symptômes cutanés associés aux pyridiniums ?\nLes symptômes varient-ils selon le type de pyridinium ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Communication#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés de pyridinium",
"description": "Quelles mesures préventives peuvent réduire l'exposition aux pyridiniums ?\nLes formations sont-elles nécessaires pour manipuler des pyridiniums ?\nComment stocker les composés de pyridinium en toute sécurité ?\nLes fuites de pyridiniums peuvent-elles être évitées ?\nQuelles sont les recommandations pour les laboratoires ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Communication#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés de pyridinium",
"description": "Quel est le traitement principal en cas d'intoxication aux pyridiniums ?\nLes soins de soutien sont-ils nécessaires pour les patients exposés ?\nQuels antidotes sont utilisés contre les pyridiniums ?\nLa dialyse est-elle efficace pour éliminer les pyridiniums ?\nComment prévenir les complications lors du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Communication#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés de pyridinium",
"description": "Quelles complications peuvent survenir après une exposition aux pyridiniums ?\nLes effets à long terme des pyridiniums sont-ils connus ?\nComment les complications sont-elles gérées ?\nLes complications peuvent-elles être évitées ?\nQuels sont les signes d'alerte pour des complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Communication#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés de pyridinium",
"description": "Quels sont les principaux facteurs de risque d'exposition aux pyridiniums ?\nL'âge influence-t-il la sensibilité aux pyridiniums ?\nLes antécédents médicaux augmentent-ils le risque d'intoxication ?\nLes conditions environnementales jouent-elles un rôle ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Communication#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux composés de pyridinium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les composés de pyridinium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses chromatographiques et spectrométriques sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux pyridiniums ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les tests urinaires peuvent-ils détecter les pyridiniums ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains tests urinaires peuvent révéler la présence de métabolites pyridiniques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux pyridiniums."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition aux pyridiniums ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des vertiges et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les composés de pyridinium provoquent-ils des effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des maux de tête, des convulsions et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux pyridiniums ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des irritations peuvent survenir après contact avec ces composés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de pyridinium ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver sans traitement approprié, nécessitant une intervention rapide."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives peuvent réduire l'exposition aux pyridiniums ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de la manipulation de ces composés."
}
},
{
"@type": "Question",
"name": "Les formations sont-elles nécessaires pour manipuler des pyridiniums ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la sécurité chimique sont essentielles pour les travailleurs exposés."
}
},
{
"@type": "Question",
"name": "Comment stocker les composés de pyridinium en toute sécurité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stocker dans des contenants hermétiques et étiquetés, à l'écart des sources de chaleur."
}
},
{
"@type": "Question",
"name": "Les fuites de pyridiniums peuvent-elles être évitées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en vérifiant régulièrement les équipements et en respectant les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les laboratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les laboratoires doivent suivre des protocoles stricts de manipulation et de stockage des pyridiniums."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication aux pyridiniums ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la décontamination et l'administration d'antidotes spécifiques."
}
},
{
"@type": "Question",
"name": "Les soins de soutien sont-ils nécessaires pour les patients exposés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien, comme l'hydratation et la surveillance, sont souvent requis."
}
},
{
"@type": "Question",
"name": "Quels antidotes sont utilisés contre les pyridiniums ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antidotes comme l'atropine peuvent être administrés pour contrer les effets toxiques."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle efficace pour éliminer les pyridiniums ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dialyse peut être envisagée dans les cas graves d'intoxication pour éliminer les toxines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications lors du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance étroite et un traitement rapide des symptômes sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition aux pyridiniums ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des lésions organiques, des troubles neurologiques et respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les effets à long terme des pyridiniums sont-ils connus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une prise en charge médicale spécialisée et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une intervention rapide et un traitement approprié peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte pour des complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des difficultés respiratoires, des convulsions ou une confusion mentale doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition aux pyridiniums ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en chimie, agriculture et industrie sont les plus exposés aux pyridiniums."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux pyridiniums ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme la chaleur ou l'humidité peuvent exacerber les effets des pyridiniums."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent augmenter la toxicité des pyridiniums."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr.
Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS) Daejeon 34141 Korea.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Potsdam, Potsdam, Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Potsdam, Potsdam, Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Xi'an Medical University, Xi'an, Shaanxi 710021, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr.
Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS) Daejeon 34141 Korea.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Georg-August Universität Göttingen , Tammannstraße 2 , 37077 Göttingen , Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Georg-August Universität Göttingen , Tammannstraße 2 , 37077 Göttingen , Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
Hospitals represent complex organizations where a range of hospital workers, from physicians to administrators, encounter a deluge of information they must quickly process and act upon. New technologi...
This essay argues that we should treat science and risk communicators' choices about tactics, objectives, and goals as behaviors to advance both research and practice. Doing so allows for a discussion...
Serious illness communication in homecare about hospice and/or palliative care transitions is lacking due to clinical culture. The purpose of the current study was to understand communication openings...
The purpose of this study was to gain a comprehensive understanding of participation situations that are challenging for people with communication problems, to provide input for the further developmen...
A purposive sampling strategy was used to include a diverse group of people with communication problems. Diaries were used as a sensitizing exercise for inductive in-depth interviews. In these intervi...
Eighteen interviews yielded 44 different concepts. They were clustered in six themes, which capture the person, location, topic, mode, moment, and pace of communication. In total, 103 new items measur...
This study resulted in an overview of self-reported barriers in daily communicative participation experienced by people with communication problems. These communicative participation situations can be...
To explore how communication is perceived and care is negotiated amongst IA healthcare teams by drawing on the perspectives of each team member....
This analysis drew on data from an ongoing three-year study exploring team-based IA care. We interviewed 11 participants including two men with IA and their family care providers and healthcare provid...
Analysis revealed three themes regarding communication and care: (1) seeking/sharing information, (2) striving to coordinate unified care, and (3) providing patients a voice....
This study emphasizes the importance of understanding team dynamics beyond the dyad of patient and care provider. Negotiating power and decision-making in IA care is a dynamic process involving shifti...
To analyze the effect of communication training developed for adolescents on the youth's communication skills....
Forty-one young people participated in the study and were divided into two groups. Group I received intervention - communication training for five weeks; Group II - were guided on the importance of vo...
The analysis of questionnaires showed improvement in GI in two of the four skills assessed and no difference for GII. The video evaluations showed a significant difference between the groups in terms ...
This study points out that the communication training method applied to young people might improve communicative skills, providing some insights into their communication strengths and potential areas ...
Humans often communicate using body movements like winks, waves, and nods. However, it is unclear how we identify when someone's physical actions are communicative. Given people's propensity to interp...
The consequences of ineffective communication between patients and clinicians in the ED range from frustration to significant adverse events. Unfortunately, scenarios where we are unable to understand...
Many people with amyotrophic lateral sclerosis (PALS) experience speech changes, which may interfere with participation in communication situations. This study was designed to investigate the effects ...
Participants with amyotrophic lateral sclerosis completed an online questionnaire in which they identified their current communication methods, rated their speech function, and rated their communicati...
Communication aids appeared to support communicative participation for many participants with dysarthria. Across all levels of speech function, PALS who use aided communication reported better partici...
Aided communication can help PALS continue to participate in various communication situations as their speech function deteriorates. Variability in self-rated communicative participation, even for PAL...
https://doi.org/10.23641/asha.22782986....
Research has found that people with communication disabilities are three times more likely to encounter medical mishaps. Almost a third of patients with speech-language therapy (SLT) diagnoses have ot...
This study aims to describe the communication challenges and strategies employed by a group of final year Nursing, Medicine, Dietetics and Human Nutrition, Physiotherapy and Occupational Therapy stude...
A qualitative, phenomenological study design was used. Questionnaires were electronically distributed, and results were analysed thematically....
The most significant challenges whilst managing adults with communication disorders were patients' receptive and expressive language difficulties. Further challenges included lack of knowledge surroun...
This study revealed that there is a need to develop healthcare students' skills in managing adults with communication disorders. This is because of the challenges faced and inefficiency of the strateg...